{"id":8624,"date":"2024-06-27T15:33:06","date_gmt":"2024-06-27T07:33:06","guid":{"rendered":"https:\/\/clinicalvalue.com\/?p=8624"},"modified":"2024-06-27T15:36:11","modified_gmt":"2024-06-27T07:36:11","slug":"the-implications-of-identifying-and-managing-hcc-surveillance-patients-in-general-practice","status":"publish","type":"post","link":"https:\/\/clinicalvalue.com\/en-au\/the-implications-of-identifying-and-managing-hcc-surveillance-patients-in-general-practice\/","title":{"rendered":"The implications of identifying and managing HCC surveillance patients in General Practice"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Dr Caran Cheung (GP working in Mascot, Sydney) discusses the implications of identifying and managing HCC surveillance patients in General Practice. Caran\u00a0has a special interest in viral hepatitis and is a s100 HBV and HIV prescriber and clinical editor working with organisations to provide health education to GPs.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_video link=&#8221;https:\/\/vimeo.com\/969463602\/8ebd4f1e90?&#8221;][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Dr Caran Cheung (GP working in Mascot, Sydney) discusses the implications of identifying and managing HCC surveillance patients in General Practice. Caran\u00a0has a special interest in viral hepatitis and is a s100 HBV and HIV prescriber and clinical editor working with organisations to provide health education to GPs.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_video link=&#8221;https:\/\/vimeo.com\/969463602\/8ebd4f1e90?&#8221;][\/vc_column][\/vc_row]&#8230;<\/p>\n","protected":false},"author":19,"featured_media":8737,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[1285],"tags":[1419,1301,1322],"cancer-type":[1296],"country":[1268],"class_list":["post-8624","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-expert-opinions-en-au","tag-gp-opinion","tag-hcc-en-au","tag-hcc-surveillance-en-au","post_format-post-format-video","cancer-type-liver-en-au","country-au"],"jetpack_featured_media_url":"https:\/\/clinicalvalue.com\/app\/uploads\/2024\/06\/Carrin-Cheung.png","_links":{"self":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8624"}],"collection":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/comments?post=8624"}],"version-history":[{"count":3,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8624\/revisions"}],"predecessor-version":[{"id":8736,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8624\/revisions\/8736"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/media\/8737"}],"wp:attachment":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/media?parent=8624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/categories?post=8624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/tags?post=8624"},{"taxonomy":"cancer-type","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/cancer-type?post=8624"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/country?post=8624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}